Does Dr. RAABIA AHMAD have financial conflicts of interest?

Dr. RAABIA AHMAD (MD) has received a total of $2,645 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,645 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAABIA AHMAD?

According to CMS Open Payments data, Dr. RAABIA AHMAD received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($418), ESPERION THERAPEUTICS ($321), and ABBOTT LABORATORIES ($306).

Does Dr. RAABIA AHMAD receive research grants or speaking fees?

Dr. RAABIA AHMAD has received $2,645 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAABIA AHMAD

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: MOUNTAIN VIEW, CA 94040

NPI Number: 1942521497

LIFETIME INDUSTRY VALUE

$2,645

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMAD is a verified Internal Medicine, Cardiovascular Disease practitioner based in MOUNTAIN VIEW, CA.

Between 2021 and 2024, Dr. AHMAD had an overall industry promotional and research financial footprint of $2,645 as recorded in the federal CMS Open Payments database.

$2,645 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMAD's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $418 (representing 15.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$418

15.8%

ESPERION THERAPEUTICS

Rank 2

$321

12.1%

ABBOTT LABORATORIES

Rank 3

$306

11.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.